TerminatedPhase 1NCT00839501

Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome

Studying Andersen-Tawil syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Rochester
Principal Investigator: Paul Twydell, DO
University of Rochester School of Medicine & Dentistry
Intervention: Potassium(dietary_supplement)
Enrollment: 3 enrolled
Eligibility: 10 years · All sexes
Timeline: 2008 – 2011

Study locations (1)

University of Rochester School of Medicine, Rochester, New York, United States

Collaborators

Office of Rare Diseases (ORD) · Rare Diseases Clinical Research Network · National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00839501 on ClinicalTrials.gov

← Back to all trials